CLINICAL TRIALS PROFILE FOR ZYPREXA ZYDIS
✉ Email this page to a colleague
All Clinical Trials for ZYPREXA ZYDIS
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000374 ↗ | Treatment for First-Episode Schizophrenia | Completed | National Institute of Mental Health (NIMH) | Phase 4 | 1998-09-01 | This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia. |
NCT00000374 ↗ | Treatment for First-Episode Schizophrenia | Completed | The Zucker Hillside Hospital | Phase 4 | 1998-09-01 | This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia. |
NCT00000374 ↗ | Treatment for First-Episode Schizophrenia | Completed | Northwell Health | Phase 4 | 1998-09-01 | This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ZYPREXA ZYDIS
Condition Name
Clinical Trial Locations for ZYPREXA ZYDIS
Trials by Country
Clinical Trial Progress for ZYPREXA ZYDIS
Clinical Trial Phase
Clinical Trial Sponsors for ZYPREXA ZYDIS
Sponsor Name